TORONTO, May 25, 2021 /CNW/ – Halo Collective Inc. (“Halo” or the “Company“) (NEO: HALO) (OTC: HCANF) (Frankfurt: A9KN) is pleased to announce that the common share purchase warrants of the Company (the “Warrants“), issued in connection with the Company’s previously announced overnight marketed public offering of units, have been approved for listing on the Neo Exchange Inc. (the “NEO“) and are expected to commence trading on or about May 27, 2021 under the symbol HALO.WT.C.

An aggregate of 65,714,450 Warrants are currently issued and outstanding. Each Warrant entitles the holder thereof to purchase one common share of the Company at an exercise price of $0.225 at any time prior to 5:00 p.m. (Toronto Time) on February 19, 2024. The Warrants were issued pursuant to, and are governed by, the terms of a warrant indenture dated February 19, 2021 between the Company and Odyssey Trust Company (the “Warrant Indenture“). A copy of the Warrant Indenture is available under the Company’s profile on SEDAR at www.sedar.com.

About Halo Collective Inc.

Halo is a leading, vertically integrated cannabis company that cultivates, extracts, manufactures, and distributes quality cannabis flower, oils, and concentrates and has sold approximately nine million grams of oils and concentrates since inception. Halo continues to evolve its business and scale efficiently, partnering with trustworthy leaders in the industry, who value the Company’s operational expertise in bringing top-tier products to market. Current growth includes expansion in key U.S. markets, the United Kingdom and Africa, with planned expansion into the Canadian retail market.

Halo is led by a strong, diverse, and innovative management team with deep industry knowledge and blue-chip experience. The Company is currently operating in the United States in California and Oregon. The Company sells cannabis products principally to dispensaries under its brands, Hush, Mojave, and Exhale, and under partnership or license with OG DNA Genetics, Terphogz and FlowerShop*, a cannabis lifestyle and conceptual wellness brand in which G-Eazy is a partner and key member of FlowerShop*.

As part of continued expansion and vertical integration in the U.S., Halo boasts several grow operations throughout Oregon and California. In Oregon, the Company has a combined 9 acres of outdoor cultivation, including East Evans Creek, a six-acre grow site in Jackson County, Blue Sky Farms, a two-acre grow site located in Jackson County and Winberry Farms, a one-acre grow site located 30 miles outside Eugene in Lane County. In California, the Company is building out Ukiah Ventures, a planned 30,000-square-foot indoor grow and cannabis processing facility, including up to an additional five acres of industrial land to expand this indoor grow site. Recently, Halo partnered with Green Matter Holding to purchase Bar X Farm in Lake County, developing up to 80 acres of cultivation which would comprise the largest grow in California.

Internationally, the Company’s subsidiary Bophelo is currently cultivating medicinal cannabis in Lesotho.  Once fully built out, Halo believes Bophelo to be one of the largest licensed marijuana cultivation sites in the world with a future capacity of up to 495 acres. To further Halo’s global presence, the Company has recently acquired CBPM importation and distribution licensing in the United Kingdom via medical cannabis suppliers Canmart. Halo expects the cultivation and manufacturing operations of Bophelo, combined with the importation and distribution capabilities of Canmart, to drive a well-positioned business to serve the U.K. market.

The Company also has acquired a range of software development assets, including technology platforms CannPOS, Cannalift, and, more recently, CannaFeels. Halo also owns the discrete sublingual dosing technology, Accudab. The Company intends to spin-off these assets along with its intellectual property and patent applications into its subsidiary Halo Tek Inc. and complete a distribution to shareholders on a record date to be determined by Halo.

For further information regarding Halo, see Halo’s disclosure documents on SEDAR at www.sedar.com

Cautionary Note Regarding Forward-Looking Information and Statements

This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities legislation and may also contain statements that may constitute “forward looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only Halo’s beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of Halo’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “plans,” “expects” or “does not expect,” “is expected,” “budget,” “scheduled,” “estimates,” “forecasts,” “intends,” “anticipates” or “does not anticipate,” or “believes,” or variations of such words and phrases or may contain statements that certain actions, events or results “may,” “could,” “would,” “might” or “will be taken,” “will continue,” “will occur” or “will be achieved”. Forward-looking information may relate to anticipated events or results including, but not limited to: the expected listing date for the Warrants, Halo’s planned expansion into the Canadian retail market, Halo’s planned operations in Malta, the expected size and capabilities of the final facility planned at Ukiah Ventures, the size of Halo’s planned cultivation facility in Northern California, the ability of Bophelo and Canmart to serve the U.K. market and Halo’s proposed joint venture with Red Light Holland Corp.

By identifying such information and statements in this manner, Halo is alerting the reader that such information and statements are subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different from those expressed or implied by such information and statements. In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Halo has made certain assumptions. Although Halo believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. Among others, the key factors that could cause actual results to differ materially from those projected in the forward-looking information and statements are the following: delays in obtaining required approvals from regulators, changes in general economic; business and political conditions, including changes in the financial markets; delays in obtaining required licenses or approvals; delays or unforeseen costs incurred in connection with construction; the ability of competitors to scale operations in Northern California; delays or unforeseen difficulties in connection with the cultivation and harvest of Halo’s raw material; and the other risks disclosed in the Company’s annual information form dated April 16, 2020 and available on the Company’s profile at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward-looking information or statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.

The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Halo does not undertake to update any forward looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. All subsequent written and oral forward looking information and statements attributable to Halo or persons acting on its behalf is expressly qualified in its entirety by this notice.

SOURCE Halo Collective Inc.

For further information: Halo Collective, Investor Relations, [email protected], www.haloco.com/investors

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

 Jushi Holdings Inc. (NEO: JUSH) made its public debut on Monday, June 10^th.  The Boca Raton-based company has assembled a highly skilled and diversified team that is moving with a purpose, building a global footprint via organic and inorganic growth to capitalize on booming demand for cannabidiol, or CBD, in North America and abroad.

According to Cowen Equity Research and Marijuana Business Daily, global legal cannabis sales are forecasted to climb from about $9.6 billion in 2017 to $75 billion in 2030. In our opinion, there is no better time to be invested in this burgeoning industry.

Additionally, CBD is a non-psychotropic molecule found in cannabis and hemp.  The US Farm Bill, passed in December 2018, allowed, states to legalize industrial hemp and CBD products within their state paving the way for interstate commerce, while setting off a race to develop new products from hemp-derived CBD.

According to a report by market analysts at the Brightfield Group published in September 2018, hemp-based CBD is expected to blossom from around $600 million in 2018 to $22 billion by 2022.

Please click here to receive an investor deck and corporate updates

Operations Across the United States

Jushi and its portfolio companies have hemp operations in New York and are in the process of securing cannabis operations in California, New York, Virginia, Pennsylvania, Ohio, and Nevada as well as additional states.  The targets in California, the biggest cannabis market in North America, include several handpicked retail cannabis locations with delivery capabilities and licenses for distribution, cultivation and processing.

In the East, Jushi is emerging as a leading player through its acquisition of Mend Products, formation of its hemp-centric subsidiary, Sound Wellness Holdings, Inc. earlier this year, and its relationship with the DENT Neurologic Institute in Buffalo, NY.

Quality is a differentiator for Jushi. All Jushi products are tested by an independent third party to ensure consistency for its premium goods, which cover the full spectrum, including oils, soft gel caps, creams, tinctures and more.  Most products on the market today do not go through any independent testing to ensure consistency across batches, safety and quality, or even CBD levels.

Meanwhile, the company’s subsidiary Sound Wellness, LLC, which earned a hemp processing license through NY’s Industrial Hemp Agricultural Research program, is moving forward with its own hemp/CBD manufacturing facility in upstate New York.  When completed, Sound Wellness will have one of the largest industrial hemp processing, extraction and manufacturing operations in the Northeastern United States.

Please click here to receive an investor deck and corporate updates

Scientific Commitment to Health and Wellness

Coupled with savvy acquisitions, partnerships and key hires, Jushi has access to private research thanks in part to Jushi’s Medical Director, Dr. Laszlo Mechtler, and Jushi’s Medical President, Steven Przybyla.  Dr. Mechtler, a world-renowned expert in cannabis and cannabis research, was a founder of Mend and still serves as Medical Director at the DENT Neurologic Institute, operator of the largest medical cannabis program in New York.

With Dr. Mechtler’s oversight, the full-spectrum CBD-hemp derived products of Mend are formulated using patient data collected from thousands of patients and formulated by board-certified physicians with a dynamic process for revisions based upon new data.  Dent’s large pool of patient data indicates substantial benefits from cannabis-derived products.  Further, Dent and Mend are in the process of initiating groundbreaking research through two planned clinical studies into the impact of Mend products.

Prior to taking on the role of President of Jushi Medical, Steven Przybyla worked as EVP of Business Development, General Counsel and Director of Cannabis Programs at DENT, strengthening the ties between Jushi and the prestigious institution.

The Mend Store held its grand opening in Dent Tower in Buffalo on June 3, 2019. While open to public, the Mend Store also expects to serve patients of DENT’s medical cannabis program. Sales have started strong and are exceeding internal estimates.

Other initiatives of the company include international expansion by Jushi Europe, which will be focused on an early stage market through a separately financed entity.

Elsewhere, Jushi recently acquired the trademarks The Clinic^TM, The Clinic Consulting Services^TM, The Bank^TM and The Lab^TM as well as, subject to certain limited exceptions, intellectual property derived from the operations of The Clinic^TM Colorado. The Clinic Colorado, a Denver-based cannabis company, is known for its intellectual property concerning cannabis cultivation, processing, retail distribution, compliance, and safety in multiple states, and has received more industry awards than any other cannabis company in the US with 32 first place awards. The Clinic Colorado has had a track record of success with The Bank^TM owning intellectual property to cultivation and genetics of over 150 different strains and the Lab’s^TM intellectual property consisting of proprietary concentrates and extraction techniques. This sophisticated IP will complement Jushi’s expanding platform.

Please click here to receive an investor deck and corporate updates

The Upshot

Piloted by Deutsche Bank corporate finance veteran Erich Mauff (Founder, President, Board Member) and experienced hedge fund manager Jim Cacioppo (Founder, CEO, Chairman of the Board), Jushi combines public company and capital markets know-how with an excellent mix of cannabis and medical executives to create a multi-state operator with a commitment to shareholder value and highest quality products.

These fundamentals underpin management and advisors investing more than $20 million of the approximately $135 million that Jushi raised since February 2018 to support growth through its diverse capital allocation methodology. With Jushi recently going public on Monday, June 10th, keep an eye on further developments as the company executes its vision of becoming a bold, new, principled leader in the cannabis and hemp industry.

Please click here to receive an investor deck and corporate updates

Disclaimer

The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.